We invite you to learn more about:
- The importance of knowing your non-Hodgkin lymphoma (NHL) subtype
- How your NHL subtype guides your treatment goals
- Treatments for slow-growing and aggressive forms of NHL
- The benefit of discussing quality-of-life concerns with your healthcare team
Transcript will be available soon.
Celeste Bello, MD, MSPH
Department of Malignant Hematology
Moffitt Cancer Center
Support for this program is provided by Bristol Myers Squibb; Genentech, Inc. & Biogen and Pharmacyclics, An AbbVie Company & Janssen Biotech.